Nipro Corporation (TYO:8086)

Japan · Delayed Price · Currency is JPY

1,446.50

+8.00 (0.56%)

Sep 14, 2026, 3:30 PM JST

Market Cap	240.43B -5.9%
Revenue (ttm)	668.86B +2.7%
Net Income	14.07B +144.4%
EPS	76.73 +145.3%
Shares Out	166.21M
PE Ratio	18.85
Forward PE	13.82
Dividend	32.00 (2.18%)
Ex-Dividend Date	Sep 29, 2026

Volume	630,000
Open	1,439.00
Previous Close	1,438.50
Day's Range	1,430.00 - 1,448.50
52-Week Range	1,401.00 - 1,760.50
Beta	-0.01
Analysts	Buy
Price Target	1,996.00 (+37.99%)
Earnings Date	Nov 10, 2026

About Nipro

Nipro Corporation, together with its subsidiaries, engages in the medical devices, pharmaceuticals, and pharma packaging businesses worldwide. The company offers renal products; interventional products, such as cardiovascular products, endovascular products, and accessories; and hospital products, including hypodermic needles, syringes, IV sets and catheters, 3-way stopcocks, infusion sets, balloon infusers, etc. It also provides cardiopulmonary products comprising oxygenators, cardioplegia heat exchangers, perfusion tubing sets, arterial filte... [Read more]

Industry Medical Instruments & Supplies

Sector Healthcare

Founded 1947

Employees 38,593

Stock Exchange Tokyo Stock Exchange

Ticker Symbol 8086

Full Company Profile

Financial Performance

In fiscal year 2026, Nipro's revenue was 660.54 billion, an increase of 2.47% compared to the previous year's 644.59 billion. Earnings were 13.50 billion, an increase of 164.11%.

Financial Statements

Analyst Summary

According to 5 analysts, the average rating for 8086 stock is "Buy." The 12-month stock price target is ¥1,996, which is an increase of 37.99% from the latest price.

Price Target

¥1,996

(37.99% upside)

Analyst Consensus: Buy

Stock Forecasts